{
    "timestamp": "Aug 4, 2025 9:02 AM EST",
    "stats": {
        "input_words": 1192952,
        "output_words": 583,
        "filings_processed": 7
    },
    "filings": [
        {
            "company_name": "Waters Corporation",
            "stock": "WAT",
            "wiki_url": "https://en.wikipedia.org/wiki/Waters_Corporation",
            "change_percent": 0,
            "price": 290.61,
            "filing_type": "10-Q",
            "filing_time": "2025-08-04T06:16:52-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1000697/000119312525172087/0001193125-25-172087-index.htm",
            "accession_number": "0001193125-25-172087",
            "summary_points": [
                "1. The company acquired all outstanding equity interests of Optofluidics, Inc. and Halo Labs LTD for $35 million (net of cash acquired) on May 20, 2025.",
                "2. As of June 28, 2025, the company's total inventories were $540.754 million, a year-over-year increase of $63.493 million.",
                "3.  A merger with Becton, Dickinson & Company's Biosciences & Diagnostic Solutions business is expected to close around the end of Q1 2026, assuming regulatory approvals and shareholder approval; the company anticipates approximately $120 million in transaction-related expenses and financing fees if the merger closes."
            ]
        },
        {
            "company_name": "Amphenol",
            "stock": "APH",
            "wiki_url": "https://en.wikipedia.org/wiki/Amphenol",
            "change_percent": 0,
            "price": 104.29,
            "filing_type": "8-K",
            "filing_time": "2025-08-04T07:08:14-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/820313/000110465925073344/0001104659-25-073344-index.htm",
            "accession_number": "0001104659-25-073344",
            "summary_points": [
                "1. Amphenol Corporation announced on August 4, 2025, a definitive agreement to acquire CommScope's Connectivity and Cable Solutions business for $10.5 billion in cash, expected to close in the first half of 2026.",
                "2.  CommScope's Connectivity and Cable Solutions business is anticipated to generate approximately $3.6 billion in sales with a 26% EBITDA margin in 2025.",
                "3. The acquisition is expected to be accretive to Amphenol's diluted EPS in the first full year after closing, excluding acquisition-related costs; however, risks include the potential for the acquisition not being completed or failing to realize expected benefits."
            ]
        },
        {
            "company_name": "DuPont",
            "stock": "DD",
            "wiki_url": "https://en.wikipedia.org/wiki/DuPont",
            "change_percent": 0,
            "price": 69.89,
            "filing_type": "8-K",
            "filing_time": "2025-08-04T06:50:41-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1666700/000166670025000035/0001666700-25-000035-index.htm",
            "accession_number": "0001666700-25-000035",
            "summary_points": [
                "1. DuPont settled legacy claims related to PFAS for $875 million on August 3, 2025, incurring a $177 million pre-tax charge in Q2 2025.",
                "2. A third-party review of remedial funding at the Parlin site may increase DuPont's future remediation costs.",
                "3.  The SEC filing contains numerous photographs and significant portions of corrupted or unreadable data."
            ]
        },
        {
            "company_name": "Idexx Laboratories",
            "stock": "IDXX",
            "wiki_url": "https://en.wikipedia.org/wiki/Idexx_Laboratories",
            "change_percent": 0,
            "price": 535.67,
            "filing_type": "8-K",
            "filing_time": "2025-08-04T06:30:59-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/874716/000110465925073304/0001104659-25-073304-index.htm",
            "accession_number": "0001104659-25-073304",
            "summary_points": [
                "1. IDEXX Laboratories, Inc. reported Q2 2025 revenue of $1,109 million, an 11% increase as reported and a 9% organic increase, compared to the same period in 2024.",
                "2.  As of August 4, 2025, IDEXX increased its 2025 revenue guidance to $4,205 million - $4,280 million, a $90 million increase at the midpoint compared to prior guidance.",
                "3. The updated 2025 EPS outlook is $12.40 - $12.76, a $0.40 increase at the midpoint compared to prior guidance, reflecting increased revenue and operating profit margin, a lower effective tax rate, and updated foreign exchange impacts."
            ]
        },
        {
            "company_name": "Waters Corporation",
            "stock": "WAT",
            "wiki_url": "https://en.wikipedia.org/wiki/Waters_Corporation",
            "change_percent": 0,
            "price": 290.61,
            "filing_type": "8-K",
            "filing_time": "2025-08-04T06:08:35-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1000697/000119312525172076/0001193125-25-172076-index.htm",
            "accession_number": "0001193125-25-172076",
            "summary_points": [
                "1. Waters Corporation exceeded its Q2 2025 sales guidance, reporting $771 million in sales, a 9% increase year-over-year (YoY).",
                "2.  Full-year 2025 constant currency sales growth guidance was raised to +5.5% to +7.5%, and non-GAAP EPS guidance increased to $12.95 to $13.05.",
                "3. Waters Corporation is undertaking a combination with BD Biosciences & Diagnostic Solutions,  with integration planning already underway."
            ]
        },
        {
            "company_name": "Loews Corporation",
            "stock": "L",
            "wiki_url": "https://en.wikipedia.org/wiki/Loews_Corporation",
            "change_percent": 0,
            "price": 90.25,
            "filing_type": "8-K",
            "filing_time": "2025-08-04T06:04:48-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/60086/000006008625000164/0000060086-25-000164-index.htm",
            "accession_number": "0000060086-25-000164",
            "summary_points": [
                "1. Loews Corporation reported a $391 million net income for the second quarter of 2025, a 6% increase year-over-year, primarily driven by strong Boardwalk Pipelines results and higher parent company investment income, offset partially by lower income from CNA Financial and Loews Hotels.",
                "2. Boardwalk Pipelines announced a final investment decision on $1.7 billion in growth projects with projected double-digit return on assets and long-term contracts (15+ years).",
                "3. Loews Hotels projects Adjusted EBITDA to grow to $400-$450 million over the next several years, nearly double pre-COVID levels, driven by recently opened hotels and future large group bookings."
            ]
        },
        {
            "company_name": "Tesla, Inc.",
            "stock": "TSLA",
            "wiki_url": "https://en.wikipedia.org/wiki/Tesla,_Inc.",
            "change_percent": 0,
            "price": 302.68,
            "filing_type": "8-K",
            "filing_time": "2025-08-04T06:03:14-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1318605/000110465925073263/0001104659-25-073263-index.htm",
            "accession_number": "0001104659-25-073263",
            "summary_points": [
                "1. Tesla granted Elon Musk a 96 million share restricted stock award on August 3, 2025, contingent on his continued service and subject to forfeiture depending on the outcome of ongoing litigation.",
                "2.  Based on August 1, 2025's closing stock price, the grant-date fair value of the award was approximately $23.7 billion, though this is for illustrative purposes only and the actual value will be determined later.",
                "3. Tesla expects no immediate compensation expense recognition for the award due to the uncertain probability of vesting, but will reassess quarterly, potentially leading to a significant cumulative catch-up expense if vesting becomes probable."
            ]
        }
    ]
}